Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toon Van Gorp

Showing results (31-40 of 168) with videos related to

Pageof 17
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 9, 2010
The use of lymph vessel markers to predict endometrial cancer outcomeIngrid Vandenput, Thomas Vanhove, Ben Van Calster, et al.
European Journal of Cancer (Oxford, England : 1990)|January 10, 2012
Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating benign from malignant adnexal massesToon Van Gorp, Joan Veldman, Ben Van Calster, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|August 24, 2017
Simple Rules, Not So Simple: The Use of International Ovarian Tumor Analysis (IOTA) Terminology and Simple Rules in Inexperienced Hands in a Prospective Multicenter Cohort StudyEvelyne Meys, Iris Rutten, Roy Kruitwagen, et al.
European Journal of Cancer (Oxford, England : 1990)|August 19, 2016
The impact of lymph node dissection and adjuvant chemotherapy on survival: A nationwide cohort study of patients with clinical early-stage ovarian cancerMarjolein Kleppe, Maaike A van der Aa, Toon Van Gorp, et al.
International Journal of Cancer|April 19, 2006
Molecular profiling of platinum resistant ovarian cancer: use of the model in clinical practiceOlivier Gevaert, Nathalie Pochet, Frank De Smet, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 3, 2014
Prognostic value of serum HE4 levels and risk of ovarian malignancy algorithm scores at the time of ovarian cancer diagnosisJeroen Kaijser, Vanya Van Belle, Toon Van Gorp, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 19, 2023
Predicting resectable disease in relapsed epithelial ovarian cancer by using whole-body diffusion-weighted MRISander Dumont, Vincent Vandecaveye, Raphaëla Carmen Dresen, et al.
Life (Basel, Switzerland)|February 26, 2025
Genetic Variants of Interleukin-8 and Interleukin-16 and Their Association with Cervical Cancer RiskRafał Watrowski, Eva Schuster, Stefan Polterauer, et al.
Biomedicines|February 24, 2024
Association of Four Interleukin-8 Polymorphisms (-251 A>T, +781 C>T, +1633 C>T, +2767 A>T) with Ovarian Cancer Risk: Focus on Menopausal Status and Endometriosis-Related SubtypesRafał Watrowski, Eva Schuster, Gerda Hofstetter, et al.
Journal of the National Cancer Institute|December 18, 2014
Costs, effectiveness, and workload impact of management strategies for women with an adnexal massLaura J Havrilesky, Michaela Dinan, Gregory P Sfakianos, et al.
Pageof 17

Showing results (31-40 of 168) with videos related to

Sort By:
Pageof 17
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 9, 2010
The use of lymph vessel markers to predict endometrial cancer outcomeIngrid Vandenput, Thomas Vanhove, Ben Van Calster, et al.
European Journal of Cancer (Oxford, England : 1990)|January 10, 2012
Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating benign from malignant adnexal massesToon Van Gorp, Joan Veldman, Ben Van Calster, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|August 24, 2017
Simple Rules, Not So Simple: The Use of International Ovarian Tumor Analysis (IOTA) Terminology and Simple Rules in Inexperienced Hands in a Prospective Multicenter Cohort StudyEvelyne Meys, Iris Rutten, Roy Kruitwagen, et al.
European Journal of Cancer (Oxford, England : 1990)|August 19, 2016
The impact of lymph node dissection and adjuvant chemotherapy on survival: A nationwide cohort study of patients with clinical early-stage ovarian cancerMarjolein Kleppe, Maaike A van der Aa, Toon Van Gorp, et al.
International Journal of Cancer|April 19, 2006
Molecular profiling of platinum resistant ovarian cancer: use of the model in clinical practiceOlivier Gevaert, Nathalie Pochet, Frank De Smet, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 3, 2014
Prognostic value of serum HE4 levels and risk of ovarian malignancy algorithm scores at the time of ovarian cancer diagnosisJeroen Kaijser, Vanya Van Belle, Toon Van Gorp, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 19, 2023
Predicting resectable disease in relapsed epithelial ovarian cancer by using whole-body diffusion-weighted MRISander Dumont, Vincent Vandecaveye, Raphaëla Carmen Dresen, et al.
Life (Basel, Switzerland)|February 26, 2025
Genetic Variants of Interleukin-8 and Interleukin-16 and Their Association with Cervical Cancer RiskRafał Watrowski, Eva Schuster, Stefan Polterauer, et al.
Biomedicines|February 24, 2024
Association of Four Interleukin-8 Polymorphisms (-251 A>T, +781 C>T, +1633 C>T, +2767 A>T) with Ovarian Cancer Risk: Focus on Menopausal Status and Endometriosis-Related SubtypesRafał Watrowski, Eva Schuster, Gerda Hofstetter, et al.
Journal of the National Cancer Institute|December 18, 2014
Costs, effectiveness, and workload impact of management strategies for women with an adnexal massLaura J Havrilesky, Michaela Dinan, Gregory P Sfakianos, et al.
Pageof 17